Deep learning predicts cardiovascular disease risks from lung cancer screening low dose computed tomography

Hanqing Chao,Hongming Shan,Fatemeh Homayounieh,Ramandeep Singh,Ruhani Doda Khera,Hengtao Guo,Timothy Su,Ge Wang,Mannudeep K. Kalra,Pingkun Yan
DOI: https://doi.org/10.1038/s41467-021-23235-4
IF: 16.6
2021-05-20
Nature Communications
Abstract:Abstract Cancer patients have a higher risk of cardiovascular disease (CVD) mortality than the general population. Low dose computed tomography (LDCT) for lung cancer screening offers an opportunity for simultaneous CVD risk estimation in at-risk patients. Our deep learning CVD risk prediction model, trained with 30,286 LDCTs from the National Lung Cancer Screening Trial, achieves an area under the curve (AUC) of 0.871 on a separate test set of 2,085 subjects and identifies patients with high CVD mortality risks (AUC of 0.768). We validate our model against ECG-gated cardiac CT based markers, including coronary artery calcification (CAC) score, CAD-RADS score, and MESA 10-year risk score from an independent dataset of 335 subjects. Our work shows that, in high-risk patients, deep learning can convert LDCT for lung cancer screening into a dual-screening quantitative tool for CVD risk estimation.
multidisciplinary sciences
What problem does this paper attempt to address?